You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pharmacokinetics and pharmacodynamics (PKPD) analysis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gout Trial in New Brunswick (Tart cherry extract 60 mL, Tart cherry extract 120 mL)

Completed
  • Gout
  • Tart cherry extract 60 mL
  • Tart cherry extract 120 mL
  • New Brunswick, New Jersey
    Robert Wood Johnson Medical School
Jan 5, 2023

Sedation Complication, Mechanical Ventilation in Neonates Trial in Brest, Corbeil-Essonnes, Créteil (Dose-effect relationship of

Not yet recruiting
  • Sedation Complication
  • Mechanical Ventilation in Neonates
  • Dose-effect relationship of morphine +/- midazolam administration
  • Brest, France
  • +2 more
Dec 1, 2022

Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South

Active, not recruiting
  • Multi-drug Resistant Tuberculosis
  • +2 more
  • Minsk, Belarus
  • +4 more
May 12, 2021

Probability of Optimal Target Attainment of Amikacin in Febrile

Recruiting
  • Febrile Neutropenia (FN)
  • Data collection: Amikacin concentration
  • Basel, Switzerland
    University Hospital Basel, Division of Internal Medicine
Jan 18, 2023

Prion Disease Trial (ION717, Placebo)

Not yet recruiting
  • Prion Disease
  • (no location specified)
Nov 29, 2023

Rheumatoid Arthritis Trial (AZD6912, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Oct 30, 2023

Sickle Cell Disease Trial (Epeleuton)

Not yet recruiting
  • Sickle Cell Disease
  • (no location specified)
May 15, 2023

Prevention of Graft Rejection After Organ Transplantation Trial in Beijing (SHR-3032, SHR-3032 Placebo)

Not yet recruiting
  • Prevention of Graft Rejection After Organ Transplantation
  • Beijing, Beijing, China
    Peking University Third Hospital
Oct 13, 2023

Healthy Participants Trial in Glendale (AZD2389, Placebo)

Not yet recruiting
  • Healthy Participants
  • Glendale, California
    Research Site
Nov 14, 2023

Thyroid Eye Disease Trial (Satralizumab, Placebo)

Not yet recruiting
  • Thyroid Eye Disease
  • (no location specified)
Oct 25, 2023

Skeletal Muscle Relaxation Trial (HRS3797)

Not yet recruiting
  • Skeletal Muscle Relaxation
  • (no location specified)
Jan 18, 2023

Thyroid Eye Disease Trial (Satralizumab, Placebo)

Not yet recruiting
  • Thyroid Eye Disease
  • (no location specified)
Aug 4, 2023

Carbapenem-resistant Enterobacteriaceae Trial in Ratchathewi (Collect blood sample)

Recruiting
  • Carbapenem-resistant Enterobacteriaceae
  • Collect blood sample
  • Ratchathewi, Bangkok, Thailand
    Phramongkutklao Hospital
Sep 17, 2023

Complement Deficiencies Trial (CSL040, Placebo)

Not yet recruiting
  • Complement Deficiencies
  • (no location specified)
Jul 6, 2023

GERD Trial in Cheongju-si (UI059, UIC202201)

Completed
  • GERD
  • Cheongju-si, Chungcheongbuk-do, Korea, Republic of
    Chungbuk national university hospital
Nov 15, 2023

Advanced Malignant Tumor Trial in Jinan (JS207)

Not yet recruiting
  • Advanced Malignant Tumor
  • Jinan, Shandong, China
    Affiliated Cancer Hospital of Shandong First Medical University
Aug 28, 2023

Healthy Volunteers Trial in Zhuhai (TNM002, Placebo)

Completed
  • Healthy Volunteers
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital Sun Yat-sen University
Apr 24, 2023

Hemophilia A Trial (NXT007)

Not yet recruiting
  • Hemophilia A
  • (no location specified)
Aug 4, 2023

Safety, Pharmacokinetics, Pharmacodynamics Trial in Overland Park (Kratom, Placebo)

Recruiting
  • Safety
  • +2 more
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc.
Oct 10, 2023

Nicotine Dependence, Nicotine Vaping Trial in San Francisco ((S)-Nicotine, (R)- nicotine, Racemic nicotine)

Not yet recruiting
  • Nicotine Dependence
  • Nicotine Vaping
  • San Francisco, California
    Zuckerberg San Francisco General Hospital (ZSFG)
Jul 17, 2023

Primary Membranous Nephropathy Trial (EVER001)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
Mar 23, 2023

Diabetes Trial (HR011408 injection; NovoRapid®, NovoRapid®;HR011408 injection)

Not yet recruiting
  • Diabetes
  • HR011408 injection; NovoRapid®
  • NovoRapid®；HR011408 injection
  • (no location specified)
Feb 12, 2023

Healthy Participants Trial in Glendale, Brooklyn (AZD4144 Part A, AZD4144 Part B, Placebo Part A)

Not yet recruiting
  • Healthy Participants
  • AZD4144 Part A
  • +3 more
  • Glendale, California
  • +1 more
Nov 3, 2023

Amyotrophic Lateral Sclerosis Trial in Melbourne (SPG302, Placebo)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • Melbourne, Victoria, Australia
    Nucleus Melbourne
May 22, 2023

Healthy Subject Trial in Seongnam, Daejeon (CT-P41, US-licensed Prolia)

Completed
  • Healthy Subject
  • CT-P41
  • US-licensed Prolia
  • Seongnam, Bundang-gu, Korea, Republic of
  • +1 more
Sep 7, 2023